Popular topics to explore

★All TopicsEquity ResearchFundamental ViewsHidden GemsIndex StrategiesIPOMacro ViewsMiscellaneousPersonal FinancePost-Closing CommentaryPre-Opening CommentaryPsychology of MoneySector BreakoutStock In NewsTechnical ViewsTime To ExitToday's Trading SetupTrending SectorsWatch Out For
‹ All Posts
Saurabh Tyagi--Clovek,Advisory
Saurabh Tyagi--Clovek,Advisory

3rd Jun 2025 · SEBI-Registered Analyst

SUNPHARMA

SUNPHARMA
announced Phase 2 trial results for SCD-044, a psoriasis drug, which failed its primary efficacy endpoint, leading to the discontinuation of related trials.

#StockInNews#WatchOutFor#FundamentalViews#MacroViews#EquityResearch